Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.4314 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.41617 | 17 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.4196 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.37888 | 18 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.36085 | 17 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.45646 | 16 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.41872 | 16 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.3925 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.38369 | 17 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.40216 | 17 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.39956 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.38811 | 17 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.40926 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.40322 | 17 |